Psyence Biomedical Warrant
PBMWW
19 hedge funds and large institutions have $122K invested in Psyence Biomedical Warrant in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 2 closing their positions.
26% more capital invested
Capital invested by funds: $96.6K → $122K (+$25K)
0% more funds holding
Funds holding: 19 → 19 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.78% less ownership
Funds ownership: 40.47% → 39.69% (-0.78%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIA
SkyView Investment Advisors
Shrewsbury,
New Jersey
|
+$502 |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$290 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$2.87K |
| 2 |
VF
Virtu Financial
New York
|
-$1K |
| 3 |
HCI
Harraden Circle Investments
New York
|
-$29 |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$9 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4 |
PBMWW Hedge Fund Activity: Q2 2026 in Review
19 of the 8,350 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical Warrant (PBMWW) for Q2 2026, worth a combined $122K — up 26% from $96.6K a quarter earlier.
Fund positioning in PBMWW was balanced in Q2 2026: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 4 trimmed.
The largest buyer was SkyView Investment Advisors, opening a new position worth an estimated $502. The largest seller was Aristeia Capital, cutting an estimated $2.87K.
- 19 institutional investors held Psyence Biomedical Warrant (PBMWW) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $122K of Psyence Biomedical Warrant stock for Q2 2026, up 26% quarter-over-quarter.
- 2 funds opened new Psyence Biomedical Warrant positions in Q2 2026 and 2 closed out, a net change of 0 holders.
- The largest Psyence Biomedical Warrant buyer in Q2 2026 was SkyView Investment Advisors, an estimated $502 added.
- The largest Psyence Biomedical Warrant seller in Q2 2026 was Aristeia Capital, an estimated $2.87K sold.
Based on aggregated 13F filings for Q2 2026.